You are here: Industry Insights > BioNTech

News List

BioNTech to acquire Novartis site for Covid-19 vaccine production pharmaceutical-technology
September 21, 2020
BioNTech has signed a share purchase agreement with Novartis to acquire a manufacturing site to boost its messenger RNA (mRNA)-based BNT162 Covid-19 vaccine candidate production capacity.
BioNTech to Acquire Novartis Mfg. Site for COVID-19 Vax Production contractpharma
September 18, 2020
Will accelerate BioNTech’s efforts to scale-up commercial manufacturing capacity for its mRNA COVID-19 vaccine candidate BNT162.
BioNTech to buy site from Novartis to boost COVID-19 vaccine production expresspharma
September 18, 2020
The financial details of the transaction have not been revealed but the facility in Germany’s Marburg will be converted to be fully on stream in the first half of 2021 with annual production capacity up to 750 million mRNA vaccine doses.
EC concludes talks with Pfizer, BioNTech for Covid-19 vaccine supply pharmaceutical-technology
September 18, 2020
The European Commission (EC) has concluded exploratory talks with Pfizer and BioNTech for the potential supply of 200 million doses of the companies’ BNT162 mRNA-based Covid-19 vaccine candidate to the European Union (EU) Member States.
Germany awards €750m to BioNTech and CureVac for Covid-19 vaccines pharmaceutical-technology
September 17, 2020
The German Government has granted a total of up to €750m in funding to domestic firms BioNTech and CureVac to support the work on their respective Covid-19 vaccine candidates.
Pfizer, Biontech Propose Expansion of Pivotal COVID-19 Vaccine Trial americanpharmaceuticalreview
September 16, 2020
Pfizer and BioNTech have submitted an amended protocol to the U.S. Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to approximately 44,000 participants which also allows for the ...
BioNTech to Receive German Federal Ministry Funding for COVID-19 Vax contractpharma
September 16, 2020
BioNTech SE will receive a grant of up to $445.4 million) from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines.
Clinical Trial of AstraZeneca COVID-19 Vaccine Paused After Illness drugs.com
September 10, 2020
A "potentially unexplained" illness in a participant has led AstraZeneca to halt a late-stage clinical trial of its COVID-19 vaccine.
Pfizer and BioNTech to supply 120 million Covid-19 vaccine doses to Japan pharmaceutical-technology
August 04, 2020
Pfizer and BioNTech have entered an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to provide 120 million doses of their BNT162 Covid-19 vaccine candidate.
Pfizer, BioNTech Reach Deal with Japanese Government contractpharma
August 04, 2020
Supply of 120 million vaccine doses to be provided in the first half of 2021, subject to regulatory approval.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page